Minamo provides innovative and eco-conscious solutions for countering nosocomial (healthcare-associated) infections linked to silicone-based medical devices. Our mission extends to preventing biofouling on orthotic devices and enhancing the biocompatibility of silicone implants.
Minamo, founded in 2023 as a spinoff from the University of Iceland by Már Másson and Vivien Nagy, emerges from the cutting-edge work of Már's research group at the Faculty of Pharmaceutical Sciences. Pioneering advancements in biopolymers and material sciences, their extensive research journey has culminated in a revolutionary discovery—a novel silicone coating engineered to deter bacterial adhesion. Recognized through grants and awards, the Minamo technology proudly stands as a patent-pending testament to innovation and impactful research.
The patent-pending Minamo coating technology consists of two steps:
The Minamo technology presents a novel approach without occupational hazards, environmental concerns or regulatory barriers.
Vivien holds an MSc degree in Pharmaceutical Sciences and is currently completing a doctoral degree in the same field at the University of Iceland. She is experienced in research and development, chitosan modification and process optimization with a distinct focus on fostering innovation and nurturing creativity. Vivien was nominated for the Outstanding Young Person (TOYP) award in 2022 by JCI Iceland.
